ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY
This disclosure provides a method for treating a subject afflicted with a cancer comprising administering to the subject a combination of therapeutically effective amounts of an isolated population of natural killer (NK) cells, preferably activated and expanded NK (NKAE) cells, and an antibody or an...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PÉREZ MARTÍNEZ, Antonio VALENTÌN QUIROGA, Jaime FERNÁNDEZ CASANOVA, Lucía VELA CUENCA, María ESCUDERO LÓPEZ, Adela GONZÀLEZ NAVARRO, Pablo |
| description | This disclosure provides a method for treating a subject afflicted with a cancer comprising administering to the subject a combination of therapeutically effective amounts of an isolated population of natural killer (NK) cells, preferably activated and expanded NK (NKAE) cells, and an antibody or an antigen-binding portion thereof that binds specifically to C-X-C Chemokine Receptor 4 (CXCR4) expressed on the surface of a cancer cell. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3765519B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3765519B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3765519B13</originalsourceid><addsrcrecordid>eNqNijEOgkAQRWksjHqHuQAFQTSWwzCEjcsuWQeFihCzVEZJ8P5xTTyA1Xvv56-jCY2omDpye_hqboseyNa5MlzATUkFSKKuKCHRFMBdExDCoLQONZyV1uyAWOsLlDYYGgqDquvWWKnYYdNvo9U0Pha_-3ETQclCVezn1-CXebz7p38P3KTHQ5YlpzxJ_7h8AC_CNJY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY</title><source>esp@cenet</source><creator>PÉREZ MARTÍNEZ, Antonio ; VALENTÌN QUIROGA, Jaime ; FERNÁNDEZ CASANOVA, Lucía ; VELA CUENCA, María ; ESCUDERO LÓPEZ, Adela ; GONZÀLEZ NAVARRO, Pablo</creator><creatorcontrib>PÉREZ MARTÍNEZ, Antonio ; VALENTÌN QUIROGA, Jaime ; FERNÁNDEZ CASANOVA, Lucía ; VELA CUENCA, María ; ESCUDERO LÓPEZ, Adela ; GONZÀLEZ NAVARRO, Pablo</creatorcontrib><description>This disclosure provides a method for treating a subject afflicted with a cancer comprising administering to the subject a combination of therapeutically effective amounts of an isolated population of natural killer (NK) cells, preferably activated and expanded NK (NKAE) cells, and an antibody or an antigen-binding portion thereof that binds specifically to C-X-C Chemokine Receptor 4 (CXCR4) expressed on the surface of a cancer cell.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240117&DB=EPODOC&CC=EP&NR=3765519B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240117&DB=EPODOC&CC=EP&NR=3765519B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PÉREZ MARTÍNEZ, Antonio</creatorcontrib><creatorcontrib>VALENTÌN QUIROGA, Jaime</creatorcontrib><creatorcontrib>FERNÁNDEZ CASANOVA, Lucía</creatorcontrib><creatorcontrib>VELA CUENCA, María</creatorcontrib><creatorcontrib>ESCUDERO LÓPEZ, Adela</creatorcontrib><creatorcontrib>GONZÀLEZ NAVARRO, Pablo</creatorcontrib><title>ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY</title><description>This disclosure provides a method for treating a subject afflicted with a cancer comprising administering to the subject a combination of therapeutically effective amounts of an isolated population of natural killer (NK) cells, preferably activated and expanded NK (NKAE) cells, and an antibody or an antigen-binding portion thereof that binds specifically to C-X-C Chemokine Receptor 4 (CXCR4) expressed on the surface of a cancer cell.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEOgkAQRWksjHqHuQAFQTSWwzCEjcsuWQeFihCzVEZJ8P5xTTyA1Xvv56-jCY2omDpye_hqboseyNa5MlzATUkFSKKuKCHRFMBdExDCoLQONZyV1uyAWOsLlDYYGgqDquvWWKnYYdNvo9U0Pha_-3ETQclCVezn1-CXebz7p38P3KTHQ5YlpzxJ_7h8AC_CNJY</recordid><startdate>20240117</startdate><enddate>20240117</enddate><creator>PÉREZ MARTÍNEZ, Antonio</creator><creator>VALENTÌN QUIROGA, Jaime</creator><creator>FERNÁNDEZ CASANOVA, Lucía</creator><creator>VELA CUENCA, María</creator><creator>ESCUDERO LÓPEZ, Adela</creator><creator>GONZÀLEZ NAVARRO, Pablo</creator><scope>EVB</scope></search><sort><creationdate>20240117</creationdate><title>ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY</title><author>PÉREZ MARTÍNEZ, Antonio ; VALENTÌN QUIROGA, Jaime ; FERNÁNDEZ CASANOVA, Lucía ; VELA CUENCA, María ; ESCUDERO LÓPEZ, Adela ; GONZÀLEZ NAVARRO, Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3765519B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PÉREZ MARTÍNEZ, Antonio</creatorcontrib><creatorcontrib>VALENTÌN QUIROGA, Jaime</creatorcontrib><creatorcontrib>FERNÁNDEZ CASANOVA, Lucía</creatorcontrib><creatorcontrib>VELA CUENCA, María</creatorcontrib><creatorcontrib>ESCUDERO LÓPEZ, Adela</creatorcontrib><creatorcontrib>GONZÀLEZ NAVARRO, Pablo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PÉREZ MARTÍNEZ, Antonio</au><au>VALENTÌN QUIROGA, Jaime</au><au>FERNÁNDEZ CASANOVA, Lucía</au><au>VELA CUENCA, María</au><au>ESCUDERO LÓPEZ, Adela</au><au>GONZÀLEZ NAVARRO, Pablo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY</title><date>2024-01-17</date><risdate>2024</risdate><abstract>This disclosure provides a method for treating a subject afflicted with a cancer comprising administering to the subject a combination of therapeutically effective amounts of an isolated population of natural killer (NK) cells, preferably activated and expanded NK (NKAE) cells, and an antibody or an antigen-binding portion thereof that binds specifically to C-X-C Chemokine Receptor 4 (CXCR4) expressed on the surface of a cancer cell.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3765519B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTI-CXCR4 ANTIBODY COMBINED WITH ACTIVATED AND EXPANDED NATURAL KILLER CELLS FOR CANCER IMMUNOTHERAPY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T20%3A57%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=P%C3%89REZ%20MART%C3%8DNEZ,%20Antonio&rft.date=2024-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3765519B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |